Description

M2e, human TFA, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A), has been remarkably conserved in all human influenza A. M2e, human TFA is a valid and versatile vaccine candidate to protect against any strain of human influenza A[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–COVID-19-anti-virus–C109H171F3N32O43S2—-[1]De Filette M, et al. Improved design and intranasal delivery of an M2e-based human influenza A vaccine. Vaccine. 2006 Nov 10;24(44-46):6597-601.—-2738.83–99.37–O=C([C@H]1N(CCC1)C([C@H]([C@H](O)C)NC([C@H](CCC(O)=O)NC([C@H](C(C)C)NC([C@H](CCC(O)=O)NC([C@H]([C@H](O)C)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@@H](N)CO)=O)=O)=O)=O)=O)=O)=O)=O)N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(N)=O)C(N[C@@H](CCC(O)=O)C(N[C@H](C(NCC(N[C@@H](CS)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CS)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@H](C(O)=O)CC(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC2=CNC3=CC=CC=C23)=O)=O)=O)=O.OC(C(F)(F)F)=O–Infection–DMSO : 100 mg/mL (ultrasonic)–Influenza Virus—-Anti-infection–Peptides